NEW ON THE MARKET
First orexin receptor antagonist for insomnia: daridorexant (QUVIVIQ)
Aldosterone antagonist finerenone (KERENDIA) for diabetic nephropathy
THERAPY FROM A CRITICAL VIEWPOINT
Chorthalidone or hydrochlorothiazide for hypertension – how to choose?
IN BRIEF
After 60 years: chlorthalidone now also available in a strength of 12.5 mg and as generic
Coumarin anticoagulants superior to new oral anticoagulants in antiphospholipid syndrome free article
CURRENT ADR NETWORK REPORT
Acute kidney injury with dapagliflozin (FORXIGA)
SIDE EFFECTS
Contact allergies and systemic adverse effects of tea tree oil
Bivalent BioNTech COVID-19 vaccine: possible risk of stroke?